Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects

NCT05905484 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Study

Interventions

DRUG: Bemnifosbuvir (BEM)
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Atea Pharmaceuticals, Inc.